Hikma Pharmaceuticals Plc Holding(s) in Company (1324W)

TIDMHIK

RNS Number : 1324W

Hikma Pharmaceuticals Plc

06 February 2017

Notification of major interests in shares

LONDON, 6 February 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals group, announces as follows:

 
 1   Identity of the issuer or the    Hikma Pharmaceuticals 
      underlying issuer of existing    PLC 
      shares to which the voting 
      rights are attached 
    -------------------------------  ---------------------- 
 
 
 2   Reason for the notification 
    ------------------------------------------  ---- 
     An acquisition or disposal of voting        Yes 
      rights 
    ------------------------------------------  ---- 
     An acquisition or disposal of financial     No 
      instruments which may result in the 
      acquisition of shares already issues 
      to which voting rights are attached 
    ------------------------------------------  ---- 
     An event changing the breakdown of voting   No 
      rights 
    ------------------------------------------  ---- 
     Other (please specify): Compliance with     No 
      the Transparency Directive 
    ------------------------------------------  ---- 
 
 
 3               Full name of the person subject                   The Capital Group Companies, 
                  to the notification obligation                    Inc. 
--------------  ------------------------------------------------  --------------------------------- 
 4               Full name of shareholders                         Refer to section 9 
--------------  ------------------------------------------------  --------------------------------- 
 5               Date of the Transaction (and                      1 February 2017 
                  date on which the threshold 
                  crossed is reached differently) 
--------------  ------------------------------------------------  --------------------------------- 
 6               Date on which the issuer notified                 3 February 2017 
--------------  ------------------------------------------------  --------------------------------- 
 7               Threshold that is crossed                         10% 
--------------  ------------------------------------------------  --------------------------------- 
 8               Notified details                                  See A, B & C below 
--------------  ------------------------------------------------  --------------------------------- 
 
 A. Voting rights attached to shares 
--------------------------------------------------------------------------------------------------- 
 Class type        Situation previous        Resulting situation after the 
  of shares         to the triggering         triggering transaction 
  (if possible      transaction 
  using the 
  ISIN code) 
----------------  ------------------------  ------------------------------------------------------- 
                   Number       Number       Number       Number of voting       % of voting 
                    of shares    of voting    of shares    rights                 rights 
                                 rights 
--------------    -----------  -----------  -----------  ---------------------  ------------------- 
                                             Direct       Direct   Indirect      Direct    Indirect 
--------------    -----------  -----------  -----------  -------  ------------  --------  --------- 
 Ordinary 
  Shares 
  (0.10 GBP) 
  GB00B0LCW083     22,321,334   22,321,334                         24,161,334              10.0691% 
----------------  -----------  -----------  -----------  -------  ------------  --------  --------- 
 
 
 
 B. Qualifying Financial instruments 
--------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
--------------------------------------------------------------------------------------- 
 Type of       Expiration   Exercise/Conversion   Number of                 % of voting 
  financial     Date         Period/Date           voting rights             rights 
  instrument                                       that may be 
                                                   acquired if 
                                                   the instrument 
                                                   if exercised/converted 
------------  -----------  --------------------  ------------------------  ------------ 
 -             -            -                     -                         - 
------------  -----------  --------------------  ------------------------  ------------ 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments 
--------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
--------------------------------------------------------------------------------------------- 
 Type of       Exercise   Expiration   Exercise/Conversion   Number of        % of voting 
  financial     Price      Date         Period/Date           voting rights    rights 
  instrument                                                  instrument 
                                                              refers to 
------------  ---------  -----------  --------------------  ---------------  ---------------- 
                                                                              Nominal   Delta 
------------  ---------  -----------  --------------------  ---------------  --------  ------ 
 -             -          -            -                     -                -         - 
------------  ---------  -----------  --------------------  ---------------  --------  ------ 
 
 
 Total A+B+C 
--------------------------------------------- 
 Number of Voting rights   % of voting rights 
------------------------  ------------------- 
       24,161,334               10.0691% 
------------------------  ------------------- 
 
 
 9   Chain of controlled undertakings through which 
      the voting rights and/or the financial instruments 
      are effectively held, if applicable 
    --------------------------------------------------------------------------------------- 
                                                             Number of    Percent 
                                                                Shares       of Outstanding 
         The Capital Group Companies, Inc. ("CG") holdings     24,161,334   10.0691% 
 
         Holdings by CG Management Companies and Funds: 
         -- Capital Research and Management Company            24,161,334   10.0691% 
    --------------------------------------------------------------------------------------- 
 
 
 Proxy Voting 
----------------------------------------- 
 10   Name of the proxy holder        N/A 
---  ------------------------------  ---- 
 11   Number of voting rights proxy 
       holder will cease to hold: 
---  ------------------------------  ---- 
 12   Date on which proxy holder 
       will cease to hold voting 
       rights: 
---  ------------------------------  ---- 
 
 
 13   Additional Information 
---  --------------------------  -------------------- 
 14   Contact name:               Christopher Aquino 
---  --------------------------  -------------------- 
 15   Contact telephone number:   +001 [phone] 
---  --------------------------  -------------------- 
 

- ENDS -

About Hikma

Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based primarily in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2015, Hikma achieved revenues of $1,440 million and profit attributable to shareholders of $252 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUNSURBSAURAR

(END) Dow Jones Newswires

February 06, 2017 07:47 ET (12:47 GMT)